Advanzeon Solutions Inc. announced on Wednesday that it has added an addendum to its Memo of Understanding with the Nevada Health CO-OP. Read More »

According to the PwC Health Research Institute’s "21st Century Pharmaceutical Collaboration: The Value Convergence" report, market forces are driving new sector collaborations to maximize real-world value and health outcomes. Read More »

Palliative Drug Care (PDC), an Oklahoma-based hospice pharmacy provider, is partnering with Relias Learning, leader in online training and compliance solutions for the healthcare market, to deliver hospice training that will advance the Palliative staff’s education and compliance. Read More »

The Commission for Certification in Geriatric Pharmacy has named American Society of Health?System Pharmacists (ASHP) an approved professional development provider to offer recertification credit hours for certified geriatric pharmacists. Read More »

Walgreens Boots Alliance Inc. on Thursday announced that its board of directors has appointed Stefano Pessina to CEO, effective immediately. Read More »

America's pharmacists remain steadfast in support of a bipartisan bill that could dramatically change their segment of the nation's healthcare industry at the federal level. Read More »

Rochester Drug Cooperative agrees to fund pharmacy to give students hands-on experience. Read More »

In the last two months, Medical Specialists Pharmacy, an online pharmacy based in the U.K., has experienced a 310 percent sales rise in their hay fever treatments. Read More »

The National Association of Chain Drug Stores (NACDS) praised passage of legislation in the U.S. House of Representatives to accelerate the pace of cures and medical breakthroughs in the United States on Friday. Read More »

Digital patient engagement solutions will be used by 10,000 retail pharmacies nationwide. Read More »

Veloxis Pharmaceuticals A/S last week announced the U.S. Food and Drug Administration approved Envarsus XR for the prophylaxis of rejection in kidney transplant patients who require or want change from other twice-daily tacrolimus products to once-daily Envarsus XR. Read More »

Gilead Sciences, Inc. said it submitted a new drug application to the U.S. Food and Drug Administration (FDA) on July 1 for an investigational, once-a-day single-tablet regimen for the treatment of HIV-1 infection in patients ages 12 and older. Read More »

Geneva Woods Pharmacy Inc. on Monday announced a big equity investment by Chugach Alaska Corporation and other Alaska-based investors, who together have acquired a minority interest in the company. Read More »

Prime Aid Pharmacy was recently awarded both URAC Specialty Pharmacy and Mail Order Pharmacy accreditation. Read More »

According to an ASHP survey, pharmacists in hospitals across the U.S. are performing more medication-related patient transition of care interventions, 24/7 medication order review and patient medication counseling. Read More »

BioPlus Specialty Pharmacy, a pioneer in innovative pharmaceutical care, on Tuesday announced the release of an updated version of the HCV Treatment Path app. Read More »

The National Community Pharmacists Association (NCPA) today announced that three teams of pharmacy students have been named finalists in the 2015 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition. Read More »

As the number of online pharmacies dispensing over the counter medicines increases, global players view India as a fertile ground for online pharmacies due to the availability of a diverse patient pool and presence of many Indian and multinational drug companies. Read More »

The Senior Care Pharmacy Coalition (CSPC) said Wednesday it commends California Gov. Jerry Brown for signing into law legislation that brings needed reforms to abusive Pharmacy Benefit Manager pricing and reimbursement practices. Ohio Gov.John Kasich signed a similar bill into law last week. Read More »

Mylan NV announced the launch of memantine hydrochloride tablets USP, 5 mg and 10 mg, the generic version of Forest's Namenda Tablets, in the United States on Tuesday. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, used for treating moderate to severe Alzheimer's-type dementia. Read More »